Cargando…
Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip?
After an injury to the central nervous system (CNS), functional recovery is limited by the inability of severed axons to regenerate and form functional connections with appropriate target neurons beyond the injury. Despite tremendous advances in our understanding of the mechanisms of axon growth, an...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347967/ https://www.ncbi.nlm.nih.gov/pubmed/32719586 http://dx.doi.org/10.3389/fncel.2020.00177 |
_version_ | 1783556695794909184 |
---|---|
author | Rodemer, William Gallo, Gianluca Selzer, Michael E. |
author_facet | Rodemer, William Gallo, Gianluca Selzer, Michael E. |
author_sort | Rodemer, William |
collection | PubMed |
description | After an injury to the central nervous system (CNS), functional recovery is limited by the inability of severed axons to regenerate and form functional connections with appropriate target neurons beyond the injury. Despite tremendous advances in our understanding of the mechanisms of axon growth, and of the inhibitory factors in the injured CNS that prevent it, disappointingly little progress has been made in restoring function to human patients with CNS injuries, such as spinal cord injury (SCI), through regenerative therapies. Clearly, the large number of overlapping neuron-intrinsic and -extrinsic growth-inhibitory factors attenuates the benefit of neutralizing any one target. More daunting is the distances human axons would have to regenerate to reach some threshold number of target neurons, e.g., those that occupy one complete spinal segment, compared to the distances required in most experimental models, such as mice and rats. However, the difficulties inherent in studying mechanisms of axon regeneration in the mature CNS in vivo have caused researchers to rely heavily on extrapolation from studies of axon regeneration in peripheral nerve, or of growth cone-mediated axon development in vitro and in vivo. Unfortunately, evidence from several animal models, including the transected lamprey spinal cord, has suggested important differences between regeneration of mature CNS axons and growth of axons in peripheral nerve, or during embryonic development. Specifically, long-distance regeneration of severed axons may not involve the actin-myosin molecular motors that guide embryonic growth cones in developing axons. Rather, non-growth cone-mediated axon elongation may be required to propel injured axons in the mature CNS. If so, it may be necessary to use other experimental models to promote regeneration that is sufficient to contact a critical number of target neurons distal to a CNS lesion. This review examines the cytoskeletal underpinnings of axon growth, focusing on the elongating axon tip, to gain insights into how CNS axons respond to injury, and how this might affect the development of regenerative therapies for SCI and other CNS injuries. |
format | Online Article Text |
id | pubmed-7347967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73479672020-07-26 Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? Rodemer, William Gallo, Gianluca Selzer, Michael E. Front Cell Neurosci Cellular Neuroscience After an injury to the central nervous system (CNS), functional recovery is limited by the inability of severed axons to regenerate and form functional connections with appropriate target neurons beyond the injury. Despite tremendous advances in our understanding of the mechanisms of axon growth, and of the inhibitory factors in the injured CNS that prevent it, disappointingly little progress has been made in restoring function to human patients with CNS injuries, such as spinal cord injury (SCI), through regenerative therapies. Clearly, the large number of overlapping neuron-intrinsic and -extrinsic growth-inhibitory factors attenuates the benefit of neutralizing any one target. More daunting is the distances human axons would have to regenerate to reach some threshold number of target neurons, e.g., those that occupy one complete spinal segment, compared to the distances required in most experimental models, such as mice and rats. However, the difficulties inherent in studying mechanisms of axon regeneration in the mature CNS in vivo have caused researchers to rely heavily on extrapolation from studies of axon regeneration in peripheral nerve, or of growth cone-mediated axon development in vitro and in vivo. Unfortunately, evidence from several animal models, including the transected lamprey spinal cord, has suggested important differences between regeneration of mature CNS axons and growth of axons in peripheral nerve, or during embryonic development. Specifically, long-distance regeneration of severed axons may not involve the actin-myosin molecular motors that guide embryonic growth cones in developing axons. Rather, non-growth cone-mediated axon elongation may be required to propel injured axons in the mature CNS. If so, it may be necessary to use other experimental models to promote regeneration that is sufficient to contact a critical number of target neurons distal to a CNS lesion. This review examines the cytoskeletal underpinnings of axon growth, focusing on the elongating axon tip, to gain insights into how CNS axons respond to injury, and how this might affect the development of regenerative therapies for SCI and other CNS injuries. Frontiers Media S.A. 2020-07-03 /pmc/articles/PMC7347967/ /pubmed/32719586 http://dx.doi.org/10.3389/fncel.2020.00177 Text en Copyright © 2020 Rodemer, Gallo and Selzer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular Neuroscience Rodemer, William Gallo, Gianluca Selzer, Michael E. Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title | Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title_full | Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title_fullStr | Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title_full_unstemmed | Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title_short | Mechanisms of Axon Elongation Following CNS Injury: What Is Happening at the Axon Tip? |
title_sort | mechanisms of axon elongation following cns injury: what is happening at the axon tip? |
topic | Cellular Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347967/ https://www.ncbi.nlm.nih.gov/pubmed/32719586 http://dx.doi.org/10.3389/fncel.2020.00177 |
work_keys_str_mv | AT rodemerwilliam mechanismsofaxonelongationfollowingcnsinjurywhatishappeningattheaxontip AT gallogianluca mechanismsofaxonelongationfollowingcnsinjurywhatishappeningattheaxontip AT selzermichaele mechanismsofaxonelongationfollowingcnsinjurywhatishappeningattheaxontip |